|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.214
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.188
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.122
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.112
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
43 |
0.101
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.095
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.089
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.088
|
|
|
maturation of 5 8s rrna from tricistronic rrna transcript ssu rrna 5 8s rrna lsu rrna
|
GO:0000466 |
1 |
0.076
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.072
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.069
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.068
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.063
|
|
|
rna processing
|
GO:0006396 |
105 |
0.060
|
|
|
methylation
|
GO:0032259 |
134 |
0.060
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.056
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.054
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.052
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.051
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
43 |
0.049
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.048
|
|
|
translation
|
GO:0006412 |
93 |
0.048
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.046
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.043
|
|
|
maturation of 5 8s rrna
|
GO:0000460 |
1 |
0.041
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.040
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.039
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.034
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.033
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.032
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.032
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.031
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.031
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.030
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.030
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.029
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.029
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.028
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.027
|
|
|
spliceosomal complex disassembly
|
GO:0000390 |
1 |
0.027
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.027
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.026
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.026
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.026
|
|
|
response to uv
|
GO:0009411 |
44 |
0.026
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.025
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.025
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
34 |
0.025
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
49 |
0.025
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.024
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.024
|
|
|
negative regulation of protein dephosphorylation
|
GO:0035308 |
2 |
0.024
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.023
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.023
|
|
|
response to camptothecin
|
GO:1901563 |
1 |
0.023
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.023
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.022
|
|
|
negative regulation of dna damage response signal transduction by p53 class mediator
|
GO:0043518 |
5 |
0.022
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.022
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.021
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.021
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.021
|
|
|
cell division
|
GO:0051301 |
120 |
0.021
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.020
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.020
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.020
|
|
|
protein processing
|
GO:0016485 |
163 |
0.020
|
|
|
mrna 3 end processing
|
GO:0031124 |
16 |
0.020
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.020
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.020
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.019
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.019
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.019
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
43 |
0.019
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.018
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.018
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.018
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.018
|
|
|
intrinsic apoptotic signaling pathway in response to oxidative stress
|
GO:0008631 |
19 |
0.018
|
|
|
positive regulation of interleukin 1 alpha production
|
GO:0032730 |
4 |
0.018
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.018
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.018
|
|
|
autophagy
|
GO:0006914 |
45 |
0.017
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.017
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.017
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.017
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.017
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.017
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.017
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.016
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.016
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.016
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.016
|
|
|
negative regulation of histone h3 k9 methylation
|
GO:0051573 |
4 |
0.016
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.016
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.016
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.016
|
|
|
rna 3 end processing
|
GO:0031123 |
20 |
0.016
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.016
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.015
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.015
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.015
|
|
|
regionalization
|
GO:0003002 |
337 |
0.015
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.015
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.015
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.015
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.015
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.015
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.015
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.015
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.015
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.015
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.014
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.014
|
|
|
rna splicing
|
GO:0008380 |
54 |
0.014
|
|
|
negative regulation of dna recombination
|
GO:0045910 |
13 |
0.014
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.014
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.014
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.014
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.014
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.014
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.014
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.014
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.014
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.014
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.014
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.013
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.013
|
|
|
gonad development
|
GO:0008406 |
141 |
0.013
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.013
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.013
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.013
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.013
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.013
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.013
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.013
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.013
|
|
|
negative regulation of ligase activity
|
GO:0051352 |
3 |
0.013
|
|
|
positive regulation of histone h3 k9 methylation
|
GO:0051574 |
4 |
0.013
|
|
|
cellular response to gamma radiation
|
GO:0071480 |
4 |
0.013
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.013
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.013
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.013
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.013
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.013
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.013
|
|
|
regulation of alpha amino 3 hydroxy 5 methyl 4 isoxazole propionate selective glutamate receptor activity
|
GO:2000311 |
11 |
0.012
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.012
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.012
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.012
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.012
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.012
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.012
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.012
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.012
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.012
|
|
|
dna repair
|
GO:0006281 |
107 |
0.012
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.012
|
|
|
trna wobble base modification
|
GO:0002097 |
2 |
0.012
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.012
|
|
|
regulation of histone h3 k9 methylation
|
GO:0051570 |
8 |
0.012
|
|
|
oocyte development
|
GO:0048599 |
33 |
0.012
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.012
|
|
|
ribosome biogenesis
|
GO:0042254 |
20 |
0.012
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.012
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.012
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.012
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.012
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.012
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.012
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.012
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.012
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.012
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.011
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.011
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.011
|
|
|
trna wobble uridine modification
|
GO:0002098 |
2 |
0.011
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.011
|
|
|
ribonucleoprotein complex subunit organization
|
GO:0071826 |
28 |
0.011
|
|
|
germline cell cycle switching mitotic to meiotic cell cycle
|
GO:0051729 |
1 |
0.011
|
|
|
histone h4 k16 acetylation
|
GO:0043984 |
3 |
0.011
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.011
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.011
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.011
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.011
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.011
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.011
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.011
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.011
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.011
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.011
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.011
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.011
|
|
|
negative regulation of gene silencing
|
GO:0060969 |
2 |
0.010
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.010
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.010
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.010
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.010
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.010
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.010
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.010
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.010
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.010
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.010
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.010
|
|